Delta Dental of Michigan, Delta Dental of North Carolina and OraLiva Inc. Announce Multi-State Launch of AI-Powered Oral Cancer Test
Read More
DURHAM, N.C., October 30, 2026 – OraLiva, Inc., an early cancer detection company developing AI-enabled cytology diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ORAL ONC-InCYT, an investigational test designed to help clinicians assess suspicious white or red oral lesions. ORAL ONC-InCYT analyzes cells collected from […]
DURHAM, NC, October 12, 2026: OraLiva, a mission-driven diagnostics company dedicated to catching cancer earlier, today announced that it has been named a Finalist in the 2026 Digital Health & AI Awards in the Rising Star track, Cancer, Screening & Early Detection category. The Digital Health & AI Awards recognize companies and innovations helping shape […]
